Ginkgo Bioworks Holdings (DNABW) Change in Cash (2020 - 2026)

Ginkgo Bioworks Holdings has reported Change in Cash for 7 years, with the latest figure at -$23.7 million in Q1 2026.

• For the quarter ending Q1 2026, Change in Cash rose 90.53% year-over-year to -$23.7 million; the trailing twelve-month figure through Mar 2026 stood at -$166.7 million (up 68.65% YoY), and the FY2025 full-year result was -$393.4 million, down 2.48% from the prior year.
• Change in Cash for Q1 2026 stood at -$23.7 million, down from $55.4 million in the prior quarter.
• The five-year high for Change in Cash was $55.4 million in Q4 2025, with the low at -$250.3 million in Q1 2025.
• Historically, Change in Cash has averaged -$82.6 million across 5 years, with a median of -$94.4 million in 2025.
• Annual changes were most pronounced in 2023 — Change in Cash slumped 536.35% — and 2025, when it surged 199.31%.
• Ginkgo Bioworks Holdings' Change in Cash stood at $24.1 million in 2022, then tumbled by 536.35% to -$105.0 million in 2023, then surged by 46.88% to -$55.8 million in 2024, then surged by 199.31% to $55.4 million in 2025, then tumbled by 142.77% to -$23.7 million in 2026.
• The last three Change in Cash figures came in at -$23.7 million (Q1 2026), $55.4 million (Q4 2025), and -$94.4 million (Q3 2025), per Business Quant data.